Moderna Inc said on Friday it had started dosing patients in a mid-stage study with its experimental coronavirus vaccine and eventually plans to enrol 600 patients for the trial.
Published : 30 May 2020, 06:54 PM
There are currently about 10 coronavirus vaccines being tested in humans and experts have predicted that a safe and effective vaccine could take 12 to 18 months from the start of development.
Earlier this month, Moderna had released data that showed the vaccine, mRNA-1273, was safe and produced protective antibodies in a small group of healthy volunteers.
The drug developer also reiterated its plans to begin late-stage trials in July.